This article is a correction to:
A dynamics association study of gut barrier and microbiota in hyperuricemia
Qiulan Lv
Jun Zhou2
Changyao Wang- 1Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China
- 2Laboratory Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
A corrigendum on
A dynamics association study of gut barrier and microbiota in hyperuricemia
by Lv, Q., Zhou, J., Wang, C., Yang, X., Han, Y., Zhou, Q., Yao, R., and Sui, A. (2023). Front. Microbiol. 14:1287468. doi: 10.3389/fmicb.2023.1287468
In the published article, there was an error in Figure 2 as published. The y-axis in Figure 2A was incorrectly labelled as “Intestinal permeability FITC-dextran (ng/ml).” The correct label is “Intestinal permeability FITC-dextran (μg/ml).” Also, the x-axis in Figure 2B was incorrectly labelled as “FITC-dextran (ng/ml).” The correct label is “FITC-dextran (μg/ml).” The corrected Figure 2 and its caption appear below.
Figure 2
Figure 2. The dynamics of intestinal permeability and proinflammatory cytokines. (A) Intestinal permeability was detected in NC and HY mice at 3, 7, 14 and 21 days by administration of FD4, and levels of serum FITC-dextran present intestinal permeability. (B) Correlation of intestinal permeability and the uric acid was analyzed using Pearson correlation coefficients. (C–E) Serum LPS (C), TNF-α (D) and IL-1β (E) levels were detected at 3, 7, 14, and 21 days using ELISA. n = 5 per group. Data are presented as the mean ± SEM. Data with different superscript letters are significantly different (p < 0.05) using one-way ANOVA followed by Tukey's multiple comparison post-test; *p < 0.05 and **p < 0.001 versus NC.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hyperuricemia, gut microbiota, intestinal barrier, dynamic changes, dyslipidemia
Citation: Lv Q, Zhou J, Wang C, Yang X, Han Y, Zhou Q, Yao R and Sui A (2024) Corrigendum: A dynamics association study of gut barrier and microbiota in hyperuricemia. Front. Microbiol. 15:1358594. doi: 10.3389/fmicb.2024.1358594
Received: 20 December 2023; Accepted: 31 January 2024;
Published: 12 February 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Lv, Zhou, Wang, Yang, Han, Zhou, Yao and Sui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ruyong Yao, yry0303@163.com; Aihua Sui, suiaihua8@126.com